News | Radiopharmaceuticals and Tracers | April 28, 2017

Australian Team Finds New Method for Producing PET Radiotracers in Higher Radiochemical Yields

New method utilizes transition metal rhenium to eliminate the need for dry conditions and purification steps

Australian Team Finds New Method for Producing PET Radiotracers in Higher Radiochemical Yields

April 28, 2017 — Researchers at the Australian Nuclear Science and Technology Organisation (ANSTO) have led the development of a new method for producing positron emission tomography (PET) radiotracers. The discovery utilizes the transition metal rhenium to promote fluorine-18 radiolabelling under aqueous, low temperature conditions. The method circumvents the need for dry conditions, and purification steps, which saves time and gives PET radiotracers in very high yields. 

Fluorine-18, the most commonly used radioisotope in PET imaging, must be attached to vectors in order to diagnose disease. The best example is where fluorine-18 is attached to glucose in order to make [18F]FDG for cancer imaging.

This new method has the potential to improve production of PET radiotracers like FDG, but also facilitate development of new radiotracers by allowing previously challenging vectors to be radiolabelled in high yields under mild conditions.  

Because a radiotracer decays, radio-synthesis needs to be performed quickly, efficiently and in high yield, so there is enough radiotracer to scan all patients at a PET medical center.  

“Improving methods for incorporation of fluorine-18 has been a longstanding challenge for the radiotracer community. This research is the first example of a rhenium promoted radio-fluorination, an unprecedented, exciting discovery in the radiochemistry field,” said senior author Benjamin Fraser, M.D., Radiotracer Method and Organic Chemistry Task leader at ANSTO.

Fraser explained that a rhenium complex was selected because of its potential for development as a dual modality PET/optical imaging agent. PET allows diagnosis of tumor location and then optical luminescence guides surgical removal of the tumor.

“The choice of rhenium proved fortuitous for the incorporation of F-18 and was good example of ‘chance favoring the prepared mind’ as the result was not predicted but very significant,” said Fraser.

“It’s also important that the reaction can be done in water, as this simplifies subsequent formulation of the radiotracer in saline for injection into a patient in a clinical setting,” he added.

The study involved the use of microfluidic technologies that had several advantages for the investigation. Giancarlo Pascali, M.D., co-senior investigator on the project who is based at the Camperdown cyclotron facility, supervised the radiochemistry work under microfluidic radiolabelling conditions.

“Microfluidic technologies allowed us to optimize all the reaction parameters very quickly, such as temperature, time, solvent and additives. We can optimize a given radiolabelling reaction in only three days, which under normal conditions would take one month to complete.

Another benefit of microfluidics is that we work with only very small amounts of radioactivity,” said Fraser.

Fraser points out that at this stage the radiotracer has not been tested for use with PET. “The next step is working on conjugating the tracer to new biological vectors, but also applying the new rhenium method to established radiotracers. We can then also investigate its potential use as a dual modality probe,” he said.

A large team of researchers from the Human Health and the Radioisotopes and Radiotracers platform at ANSTO, Curtin University, The University of Sydney, Monash University and Western Sydney University contributed to the study, which has just been published in Chemistry – A European Journal.

Ph.D. student Mitchell Klenner, who received an Australian Institute of Nuclear Science and Engineering (AINSE) post graduate scholarship, has been invited to present the work at The International Symposium on Radiopharmaceutical Sciences in May 2017.

Klenner will receive the prestigious Wiley Award at the conference in recognition of the impact of the work. Recently he also presented the work at Innovations and Radiation Applications 2017 in Wollongong and received the industry-sponsored award for best student presentation.

Fraser said, “It is fantastic to see Mitchell get due recognition for his diligent, hard work. His passion and enthusiasm for research at ANSTO is inspiring.”

For more information: www.onlinelibrary.wiley.com

Related Content

United Imaging Announces First U.S. Clinical Installation of uExplorer Total-body PET/CT
News | PET-CT | August 15, 2019
United Imaging announced that its uExplorer total-body positron emission tomography/computed tomography (PET/CT) system...
ASRT Supports Radiopharmaceutical Reimbursement Bill
News | Radiopharmaceuticals and Tracers | August 02, 2019
The American Society of Radiologic Technologists (ASRT) announced its support for House Resolution (HR) 3772, a measure...
International Multidisciplinary Group Publishes Recommendations for Personalized HCC Treatment With Y90 TheraSphere
News | Interventional Radiology | July 31, 2019
New consensus recommendations for personalized treatment for hepatocellular carcinoma (HCC) with BTG’s TheraSphere have...
NorthStar Medical Radioisotopes Awarded $30 Million by U.S. Department of Energy
News | Radiopharmaceuticals and Tracers | July 26, 2019
NorthStar Medical Radioisotopes LLC has been awarded $15 million in a cooperative agreement with the U.S. Department of...
NorthStar Medical Radioisotopes Completes Construction on Beloit, Wis. Molybdenum-99 Processing Facility
News | Radiopharmaceuticals and Tracers | July 16, 2019
NorthStar Medical Radioisotopes LLC  announced completion of construction on its 20,000-square-foot molybdenum-99 (Mo-...
Bracco Imaging Acquires Blue Earth Diagnostics
News | Radiopharmaceuticals and Tracers | July 01, 2019
Bracco Imaging S.p.A. has signed a definitive agreement to acquire Blue Earth Diagnostics, a molecular imaging company...
DOSIsoft Receives FDA 510(k) Clearance for Planet Onco Dose Software
Technology | Information Technology | June 20, 2019
DOSIsoft announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Planet...
United Imaging Announces First U.S. Clinical Install of uMI 550 Digital PET/CT System
News | PET-CT | June 19, 2019
United Imaging announced the first U.S. clinical installation of the uMI 550 Digital positron emission tomography/...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Magnetic Resonance Imaging (MRI) | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...